Therefore, the identification of a previously unrecognized binding pocket for the N-terminus presents a promising opportunity for designing peptide therapeutics that modulate P2Y2R activity, offering potential treatment for chronic inflammatory diseases, cancer, and other conditions15. Here, P2RY2 is linked to cancer.